Rosario Pivonello Selected Research

MTOR Inhibitors

1/2019	IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer.
6/2017	Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study.
6/2012	The role of mTOR inhibitors in the inhibition of growth and cortisol secretion in human adrenocortical carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosario Pivonello Research Topics

Disease

56	Acromegaly 04/2024 - 07/2002
54	Neoplasms (Cancer) 08/2023 - 03/2003
42	Cushing Syndrome 10/2023 - 05/2003
37	Pituitary Neoplasms (Pituitary Adenoma) 10/2022 - 04/2003
34	Pituitary ACTH Hypersecretion 01/2023 - 03/2003
23	Prolactinoma (Prolactinomas) 05/2024 - 06/2002
20	Adenoma (Adenomas) 12/2023 - 03/2003
16	Hypertension (High Blood Pressure) 11/2022 - 05/2003
16	Insulin Resistance 01/2021 - 06/2005
11	Hyperprolactinemia 12/2023 - 06/2002
10	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 06/2003
9	Parkinson Disease (Parkinson's Disease) 01/2017 - 04/2005
8	Adrenal Insufficiency (Adrenal Gland Hypofunction) 03/2024 - 08/2015
8	Diabetes Mellitus 03/2024 - 05/2003
8	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022 - 09/2005
7	Obesity 05/2023 - 05/2003
7	Cardiomyopathies (Cardiomyopathy) 07/2019 - 07/2002
6	Body Weight (Weight, Body) 12/2022 - 01/2019
6	Adrenocortical Carcinoma 01/2022 - 06/2012
6	Glucose Intolerance 08/2015 - 03/2008
5	Hirsutism 12/2022 - 01/2016
5	Infections 11/2022 - 01/2018
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 01/2007
5	Multiple System Atrophy 11/2010 - 04/2005
4	Adrenal incidentaloma 11/2022 - 09/2007
4	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2003
4	COVID-19 12/2021 - 01/2020
4	Hyperglycemia 01/2021 - 08/2015
4	Thyroid Neoplasms (Thyroid Cancer) 01/2017 - 04/2005
4	Cardiovascular Diseases (Cardiovascular Disease) 02/2016 - 11/2007
4	Abdominal Obesity 01/2016 - 06/2005
4	Osteoporosis 01/2016 - 09/2007
3	Addison Disease (Addison's Disease) 03/2024 - 01/2005
3	Pituitary Diseases (Disease, Anterior Pituitary) 02/2023 - 04/2003
3	Hypokalemia 10/2022 - 01/2020
3	Inflammation (Inflammations) 01/2022 - 04/2005
3	Weight Gain 01/2022 - 01/2018
3	Dyslipidemias (Dyslipidemia) 12/2021 - 10/2009
3	Cognitive Dysfunction 11/2019 - 02/2013
3	Heart Failure 07/2019 - 01/2004
3	ACTH-Secreting Pituitary Adenoma 01/2019 - 09/2007
3	Diarrhea 04/2016 - 08/2015
3	Nausea 04/2016 - 08/2015
3	Hyperplasia 08/2014 - 01/2003
3	Carcinoma (Carcinomatosis) 01/2010 - 09/2004
2	Overweight 05/2024 - 01/2024
2	Chronic Disease (Chronic Diseases) 04/2024 - 01/2023
2	Type 2 Diabetes Mellitus (MODY) 03/2024 - 10/2016
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2024 - 01/2005
2	Vitamin D Deficiency 01/2022 - 06/2020

Drug/Important Bio-Agent (IBA)

44	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2024 - 03/2003
38	Insulin-Like Growth Factor I (IGF-1)IBA 01/2024 - 07/2002
33	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2021 - 02/2003
30	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 02/2004
28	Cabergoline FDA LinkGeneric 01/2023 - 06/2002
27	Growth Hormone (Somatotropin)IBA 12/2023 - 04/2003
23	Dopamine Agonists (Dopamine Agonist)IBA 12/2023 - 06/2002
22	Octreotide (Sandostatin)FDA LinkGeneric 04/2024 - 01/2003
19	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2022 - 05/2004
17	GlucocorticoidsIBA 03/2024 - 04/2005
17	pasireotideIBA 01/2023 - 05/2007
17	Insulin (Novolin)FDA Link 12/2021 - 02/2004
14	ProlactinIBA 03/2024 - 06/2002
13	lanreotide (Somatuline)FDA Link 04/2024 - 04/2003
13	Hormones (Hormone)IBA 03/2024 - 06/2002
13	Testosterone (Sustanon)FDA Link 05/2023 - 01/2003
11	LipidsIBA 01/2022 - 05/2007
10	Dopamine Receptors (Dopamine Receptor)IBA 01/2021 - 04/2004
9	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2023 - 04/2003
7	OsilodrostatIBA 12/2022 - 04/2014
6	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2023 - 08/2015
6	Bromocriptine (Parlodel)FDA LinkGeneric 01/2022 - 06/2002
6	Insulin-Like PeptidesIBA 09/2019 - 01/2004
5	pegvisomant FDA LinkGeneric 01/2024 - 03/2006
5	relacorilantIBA 10/2023 - 01/2020
5	Vitamin D FDA LinkGeneric 01/2022 - 02/2016
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2008
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2014
4	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 07/2019 - 04/2005
4	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 04/2008
4	Arginine (L-Arginine)FDA Link 10/2010 - 04/2005
4	Dopamine Agents (Dopaminergic Agents)IBA 01/2010 - 06/2002
3	SteroidsIBA 03/2024 - 09/2007
3	LDL CholesterolIBA 12/2022 - 11/2011
3	Ketoconazole (Nizoral)FDA LinkGeneric 10/2022 - 08/2015
3	Mifepristone (RU 486)FDA Link 01/2021 - 08/2015
3	Protein Isoforms (Isoforms)IBA 11/2019 - 04/2004
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2019 - 12/2003
3	MTOR InhibitorsIBA 01/2019 - 06/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 01/2017
3	AntibodiesIBA 06/2007 - 04/2003
2	CadmiumIBA 08/2023 - 10/2017
2	AntioxidantsIBA 07/2023 - 01/2022
2	Gonadal Steroid Hormones (Sex Hormones)IBA 05/2023 - 01/2021
2	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 08/2013

Therapy/Procedure

59	Therapeutics 04/2024 - 03/2003
15	Radiotherapy 12/2023 - 04/2007
6	Adrenalectomy 05/2021 - 11/2013
5	Drug Therapy (Chemotherapy) 06/2020 - 01/2006
4	Aftercare (After-Treatment) 01/2021 - 01/2003